Will Medtronic one day be known as a diagnostics, population management company? In an interview after the panel, Riff said that Medtronic is looking at broadening its strategy by adopting the “adjacency model” conceived by Bain & Company Partner Chris Zook. The strategy revolves around taking a company’s core business, look at multiple dimensions around those core businesses – in Medtronic’s case it would be physicians, patients, technology, customer – and move a step at a time in adjacent directions away from, but related to the core business.
How Chinese country of origin rules ultimately hurt U.S. medical device manufacturing jobs. The Asian nation is requiring any imported medical device to be registered for sale in China be approved in the nation where it is being manufactured. In other words, if the imported product is being manufactured in the U.S., it needs to have marker clearance domestically before it can be registered for sale in China. It’s part of the so-called “country of origin” requirements.
Mayo Clinic holding a contest to know how effective social media is in healthcare. The Center announced Tuesday that it is holding a contest whereby researchers will measure and validate whether social media tools can promote health, help in research study subject recruitment and educate patients among other things. Researchers are being invited to submit abstracts for the contest, which will beheld in conjunction with the annual member meeting of Mayo’s Social Media Health Network, Oct. 18-19.
3 mobile technologies transforming diabetes management. These devices or programs all use wireless technology to provide real-time reminders and alerts, and translate and interpret data over a certain length of time. Some applications have the added functionality of allowing users to share data with caregivers and physicians and feed educational materials to the patient based on trends identified. They fall under the three following categories.
Fog machines, vaccines and 3 more innovations to reduce hospital-acquired infections. Rather than battling to create new drugs for these bacteria, some healthcare companies are operating by the old adage that prevention is key and are attempting to prevent infections in the first place.
[Photo from jscreationzs]